Johns Hopkins Diabetes Guide
Oxybutynin
INDICATIONS
FDA
FDA
- Symptoms of uninhibited or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).
- Overactive bladder
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: June 5, 2019
Citation
Patel, Nisha K, and Stacy E Dalpoas. "Oxybutynin." Johns Hopkins Diabetes Guide, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547110/all/Oxybutynin.
Patel NK, Dalpoas SE. Oxybutynin. Johns Hopkins Diabetes Guide. 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547110/all/Oxybutynin. Accessed December 1, 2023.
Patel, N. K., & Dalpoas, S. E. (2019). Oxybutynin. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547110/all/Oxybutynin
Patel NK, Dalpoas SE. Oxybutynin [Internet]. In: Johns Hopkins Diabetes Guide. ; 2019. [cited 2023 December 01]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547110/all/Oxybutynin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oxybutynin
ID - 547110
A1 - Patel,Nisha,Pharm.D.
AU - Dalpoas,Stacy,Pharm.D.
Y1 - 2019/06/05/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547110/all/Oxybutynin
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
